Receive regular headline summaries whenever high-quality news is generated for this page. We'll never share your email address with others.
|9/15/2022||Cost Of Cancer Treatment Can Impact Health Of Survivors - Public News Time
Drs. Steven Coughlin, from left, Jorge Cortes and Biplab Datta. Credit: Michael Holahan, Augusta University A significant number of people who have survived cancer are living in poverty, which can have negative effects on their physical and mental health, according to researchers at the Medical College of Georgia and the ...
|8/3/2022||Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q2 2022 Results - Earnings Call Transcript
... Rodriguez - President and Chief Executive Officer Dave Santos - Executive Vice President and Chief Commercial Officer Wolfgang Dummer - Executive Vice President and Chief Medical Officer Dean Schorno - Executive Vice President and Chief Financial Officer Jorge Cortes - Director, Georgia Cancer Center. Augusta University Conference Call Participants Eun Yang - Jefferies Joe Pantginis - H.C ...
|11/22/2020||Georgia Cancer Center Offers Skin Cancer Screenings on Phone
... 12:01 a.m. More By TOM CORWIN, Augusta Chronicle AUGUSTA, Ga. (AP) Dr. Loretta Davis takes the device attached to her iPhone and presses it against a sunspot on the wrist of Dr. Jorge Cortes, the director of the Georgia Cancer Center at Augusta University. After glancing at the sharp ...
|U.S. News & World Report|
|5/29/2020||Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML | Business & Finance | manchestertimes.com
... phase CML patients who are resistant or intolerant to prior TKIs - which was demonstrated in the 45-mg followed by dose reduction to 15-mg regimen - while maintaining a manageable safety profile,” said Jorge Cortes, MD, Georgia Cancer Center at Augusta University, and an OPTIC trial principal investigator. “It is ...
|1/1/2020||UGA researcher featured in Georgia Trend
... at Georgia State University's Institute for Biomedical Sciences, left, and Russell Allen, president and CEO of the Georgia Research Alliance Credit: jenniferstalcup.com Labor Day weekend was a bit of a blur for Dr. Jorge Cortes. As the rest of the country celebrated the end of summer, he and his family ...
|11/22/2019||Bio-Path’s Shares Dip on IND Application Approval||investingnews.com|
|11/21/2019||Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002||financialbuzz.com|
|10/28/2019||Rafael Pharmaceuticals Reaches Milestone of 25 Active Sites for Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)||Globe Newswire|
|9/16/2019||Peer-Reviewed Journal Future Oncology Publishes Two Manuscripts on Cancer Metabolism and Drug Candidate CPI-613® (Devimistat)||Globe Newswire|